GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Odonate Inc (OTCPK:ODTCD) » Definitions » Operating Margin %

Odonate (Odonate) Operating Margin % : 0.00% (As of Sep. 2021)


View and export this data going back to 2017. Start your Free Trial

What is Odonate Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Odonate's Operating Income for the three months ended in Sep. 2021 was $-4.08 Mil. Odonate's Revenue for the three months ended in Sep. 2021 was $0.00 Mil. Therefore, Odonate's Operating Margin % for the quarter that ended in Sep. 2021 was 0.00%.

The historical rank and industry rank for Odonate's Operating Margin % or its related term are showing as below:


ODTCD's Operating Margin % is not ranked *
in the Diversified Financial Services industry.
Industry Median: 6.23
* Ranked among companies with meaningful Operating Margin % only.

Odonate's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Odonate's Operating Income for the three months ended in Sep. 2021 was $-4.08 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Sep. 2021 was $-91.90 Mil.


Odonate Operating Margin % Historical Data

The historical data trend for Odonate's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Odonate Operating Margin % Chart

Odonate Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Operating Margin %
Get a 7-Day Free Trial - - - - -

Odonate Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Odonate's Operating Margin %

For the Shell Companies subindustry, Odonate's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Odonate's Operating Margin % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Odonate's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Odonate's Operating Margin % falls into.



Odonate Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Odonate's Operating Margin % for the fiscal year that ended in Dec. 2020 is calculated as

Operating Margin %=Operating Income (A: Dec. 2020 ) / Revenue (A: Dec. 2020 )
=-127.433 / 0
= %

Odonate's Operating Margin % for the quarter that ended in Sep. 2021 is calculated as

Operating Margin %=Operating Income (Q: Sep. 2021 ) / Revenue (Q: Sep. 2021 )
=-4.075 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Odonate  (OTCPK:ODTCD) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Odonate Operating Margin % Related Terms

Thank you for viewing the detailed overview of Odonate's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Odonate (Odonate) Business Description

Traded in Other Exchanges
N/A
Address
3 East 28th Street, 10th Floor, New York, NY, USA, 10016
Odonate Inc is a Shell company.
Executives
Ecor1 Capital, Llc 10 percent owner 357 TEHAMA STREET #3, SAN FRANCISCO CA 94103
Boxer Capital, Llc director, 10 percent owner 12860 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130
Kevin C Tang director, 10 percent owner, officer: Chief Executive Officer 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
Aaron I. Davis director, 10 percent owner 12860 EL CAMINO REAL, SUITE 300, SAN DIEGO CA 92130
Craig A Johnson director C/O PURE BIOSCIENCE, 1725 GILLESPIE WAY, EL CAJON CA 92020
Jeff L Vacirca director 4747 EXECUTIVE DRIVE, SUITE 510, SAN DIEGO CA 92121
Laura L. Johnson director C/O LA JOLLA PHARMACEUTICAL COMPANY, LA JOLLA VILLAGE DRIVE, SUITE 1070, SAN DIEGO CA 92122
Michael S Hearne officer: Chief Financial Officer 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Joseph P O'connell officer: Chief Medical Officer 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Boxer Asset Management Inc. 10 percent owner CAY HOUSE, EP TAYLOR DRIVE N7776, LYFORD CAY, NEW PROVIDENCE C5 00000
Robert Rosen director C/O HERON THERAPEUTICS, INC, 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO CA 92121
Joseph Lewis 10 percent owner PO BOX N7776, LYFORD BAHAMAS
Tang Capital Management Llc 10 percent owner 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
Tang Capital Partners Lp 10 percent owner 4747 EXECUTIVE DRIVE, SUITE 210, SAN DIEGO CA 92121
John G Lemkey officer: Chief Financial Officer 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121

Odonate (Odonate) Headlines

From GuruFocus

3 Net Current Asset Value Stock Picks

By Alberto Abaterusso Alberto Abaterusso 05-11-2021

Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $4.2 million of Shares

By GuruFocus Research GuruFocus Editor 12-23-2020

Weekly CEO Buys Highlight

By Joy Hu Joy Hu 12-28-2020